A breakdown of the latest mutual funds holding Metlife Inc (MET)

Stocks of Metlife Inc (NYSE:MET) traded higher last session on Wall Street, up 0.77% to $71.73.

MET stock price is now 0.06% away from the 50-day moving average and 3.58% away from the 200-day moving average. The market capitalization of the company currently stands at $50.23B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target maintained at $80, Goldman recently Upgraded its rating from Neutral to Buy for Metlife Inc (NYSE: MET). , while ‘Deutsche Bank’ rates the stock as ‘Hold’

In other news, PAPPAS BILL, EVP, Global Tech. & Ops. sold 27,000 shares of the company’s stock on Mar 18 ’24. The stock was sold for $1,951,325 at an average price of $72.27. Upon completion of the transaction, the EVP, Global Tech. & Ops. now directly owns 57,768 shares in the company, valued at $4.14 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 13 ’24, President, U.S. Business TADROS RAMY sold 4,026 shares of the business’s stock. A total of $289,479 was realized by selling the stock at an average price of $71.90. This leaves the insider owning 146,981 shares of the company worth $10.54 million. A total of 16.24% of the company’s stock is owned by insiders.

During the past 12 months, Metlife Inc has had a low of $57.91 and a high of $79.34. According to the stock market information, the enterprise value for the company is $70359121920, which is based on a 19.36 price-to-earnings ratio, a 1.68 price-to-earnings-growth ratio, and a beta of 1.04. The fifty day moving average price for MET is $71.6886 and a two-hundred day moving average price translates $69.24875 for the stock.

The latest earnings results from Metlife Inc (NYSE: MET) was released for 2024-06-30. The net profit margin was 3.94% and return on equity was 10.12% for MET. The company reported revenue of $17.82 billion for the quarter, compared to $16.62 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.22 percent.

Related Posts